Publications [#276906] of Kathleen A. Welsh-Bohmer

Journal Articles

1. Roses, AD; Lutz, MW; Saunders, AM; Goldgaber, D; Saul, R; Sundseth, SS; Akkari, PA; Roses, SM; Gottschalk, WK; Whitfield, KE; Vostrov, AA; Hauser, MA; Allingham, RR; Burns, DK; Chiba-Falek, O; Welsh-Bohmer, KA (2014). African-American TOMM40'523-APOE haplotypes are admixture of West African and Caucasian alleles.. Alzheimers Dement, 10(6), 592-601.e2. [doi]
   (last updated on 2025/06/16)

   Abstract:
   BACKGROUND: Several studies have demonstrated a lower apolipoprotein E4 (APOE ε4) allele frequency in African-Americans, but yet an increased age-related prevalence of AD. An algorithm for prevention clinical trials incorporating TOMM40'523 (Translocase of Outer Mitochondria Membrane) and APOE depends on accurate TOMM40'523-APOE haplotypes. METHODS: We have compared the APOE and TOMM40'523 phased haplotype frequencies of a 9.5 kb TOMM40/APOE genomic region in West African, Caucasian, and African-American cohorts. RESULTS: African-American haplotype frequency scans of poly-T lengths connected in phase with either APOE ε4 or APOE ε3 differ from both West Africans and Caucasians and represent admixture of several distinct West African and Caucasian haplotypes. A new West African TOMM40'523 haplotype, with APOE ε4 connected to a short TOMM40'523 allele, is observed in African-Americans but not Caucasians. CONCLUSION: These data have therapeutic implications for the age of onset risk algorithm estimates and the design of a prevention trial for African-Americans or other mixed ethnic populations.